George Simeakis | Medicine and Health Sciences | Best Researcher Award

Posted on by Popular Scientist

Dr. George Simeakis | Medicine and Health Sciences | Best Researcher Award

Consultant Endocrinologist 401 General Military Hospital of Athens Greece

Dr. George Simeakis is a dedicated Greek endocrinologist with a remarkable career spanning over a decade. Currently serving as a Consultant Endocrinologist and Training Program Coordinator at the 401 General Military Hospital of Athens, he specializes in thyroid cancer and endocrine neoplasia. His contributions to thyroid cancer management and advanced endocrinology have made him a respected figure in his field.

Profile

Scopus

Orcid

Education 🎓

  • Ph.D. (Athens University School of Medicine, 2014–2024): Focused on the effects of glucocorticoids on bone metabolism in multiple sclerosis patients.
  • Subspecialty training in Thyroid Cancer (Alexandra Hospital, Athens, 2019–2021).
  • Visiting Fellow (Thyroid Oncology, Pisa, Italy, 2021).
  • Residency in Endocrinology (Alexandra Hospital, Athens).
  • Residency in Internal Medicine (401 General Military Hospital, Athens).

Experience đź’Ľ

  • Teacher, National and Kapodistrian University of Athens (Postgraduate Program in Endocrine Neoplasias, 2023–Present).
  • Consultant Endocrinologist, Thyroid Cancer Outpatient Clinic (2021–Present).
  • Training Program Coordinator, 401 General Military Hospital.
  • Private Practice Endocrinologist (Since 2013).
  • Sub-investigator and researcher in groundbreaking projects on thyroid cancer, circulating tumor markers, and more.

Research Interests 🔬

Dr. Simeakis’s research focuses on:

  • Thyroid cancer diagnostics and treatment, including radiofrequency ablation techniques.
  • Circulating tumor DNA (ctDNA) and cells (CTCs) in endocrine malignancies.
  • Bone health in autoimmune disorders like multiple sclerosis.

Awards & Honors 🏆

  • D. Ikkos Award (2024): Best publication in clinical endocrinology.
  • Chairmanship of Basic Cancer Symposium, 46th European Thyroid Association Meeting (2024).
  • Discussion Leader, Medullary Thyroid Cancer Poster Session (2024).

Publications Top Notes: đź“š

“Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer: Initial Experience in Greece”
Biomedicines, 2025. Read here
Cited by: 12 articles.

“Metastatic Medullary Thyroid Carcinoma: Disease Course, Treatment Modalities and Drug Resistance”
Endocrine, 2023. Read here
Cited by: 25 articles.

“High-Dose Intravenous Steroid Treatment in Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study”
Biomedicines, 2023. Read here
Cited by: 15 articles.

“Management of Endocrine Disease: Medullary Thyroid Cancer and Future Perspectives”
European Journal of Endocrinology, 2022. Read here
Cited by: 20 articles.

 

Stefano Stefano | Medicine and Health Sciences | Best Researcher Award

Posted on by Popular Scientist

Dr. Stefano Stefano | Medicine and Health Sciences | Best Researcher Award

MD, Specializing in Rheumatology (4th year) University of Bari, Rheumatology Unit Italy

👨‍⚕️ Stefano Stano is a 4th-year MD specializing in Rheumatology at the University of Bari “Aldo Moro,” Polyclinic Hospital. His passion for rheumatology and medical research drives his active involvement in clinical and translational studies, focusing on systemic sclerosis, Sjögren’s disease, and other connective tissue disorders. Stefano aspires to pursue a Ph.D. and build an academic career contributing to advancements in rheumatology.

Profile

Orcid

Education

🎓 Stefano holds an MD and is in the final year of his specialization in Rheumatology at the University of Bari “Aldo Moro.” His academic journey is marked by consistent dedication to both theoretical and practical aspects of his field.

Experience

đź©ş With over 5 years of daily involvement in research and clinical practice, Stefano balances laboratory experiments and outpatient assessments. His hands-on approach to rheumatic diseases has honed his skills in addressing complex cases and conducting in-depth studies.

Research Interests

🔬 Stefano’s research is centered on rheumatic diseases, with a special emphasis on systemic sclerosis and Sjögren’s syndrome. He is particularly interested in exploring translational approaches that bridge laboratory findings with clinical applications.

Awards

🏅 Stefano aims to secure the Best Researcher Award in recognition of his efforts in advancing rheumatological research. His dedication and achievements position him as a strong contender.

Publications Top Notes: 

📚 Stefano’s contributions to the field are evidenced by his peer-reviewed publications, which include studies on targeted therapies, systemic sclerosis, and rheumatoid arthritis. His works have been published in reputed journals:

Cacciapaglia F, et al. (2022). Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis. J Pers Med. Read here.

Fornaro M, et al. (2022). Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry. Eur J Clin Invest. Read here.

Cacciapaglia F, et al. (2022). Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review. Journal of Scleroderma and Related Disorders. Read here.

De Luca G, et al. (2024). Rituximab retention rate in systemic sclerosis: a long-term real-life multicenter study. Rheumatology. Read here.

Iannone C, et al. (2024). Pulmonary and extra-pulmonary effects of lung transplantation in systemic sclerosis. Rheumatology. Read here.

De Lorenzis E, et al. (2024). Long-term retention rate, adverse event temporal patterns, and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. Read here.

Fornaro M, et al. (2024). Effectiveness of tapering rituximab dose in idiopathic inflammatory myopathies: Real-world data from a monocentric study. Joint Bone Spine. Read here.

Stano S, et al. (2024). Anti-aquaporin-5 and anti-poly-U-binding-factor-60kDa protein antibodies in primary Sjögren’s disease patients: Preliminary data and correlation with disease activity indices. Clin Exp Rheumatol. Read here.

Cacciapaglia F, et al. (2024). Modulation of IL-6 receptor/STAT3 downstream signaling in rheumatoid arthritis patients. Exp Mol Pathol. Read here.

 

Pasquale Viggiano | Medicine and Health Sciences | Best Researcher Award

Posted on by Popular Scientist

Assist. Prof. Dr. Pasquale Viggiano | Medicine and Health Sciences | Best Researcher Award

Ricercatore University of Bari: Universita degli Studi di Bari Aldo Moro Italy

👨‍⚕️ Dr. Pasquale Viggiano, born on January 31, 1990, in Santa Maria Capua Vetere, Italy, is a distinguished ophthalmologist and researcher. With a robust academic background and practical expertise, he is currently a researcher in Ophthalmology at the Department of Biomedicine Translation and Neuroscience, University of Bari “Aldo Moro.”

Profile

Orcid

Education

🎓 Residency in Ophthalmology (2016-2020): University G. D’Annunzio Chieti-Pescara, Italy, guided by Prof. Leonardo Mastropasqua and Prof. Paolo Carpineto.
🎓 Medical Degree (2009-2015): Catholic University of Sacred Heart, Rome, Italy. Graduated on October 19, 2015.
🎓 Fellowship in Cataract Surgery (2023): Eye Research Center and Dr. Agarwal’s Eye Hospital, Chennai, India.

Experience

🔬 Current Position:

  • Since 2022: Researcher Ophthalmologist, University of Bari “Aldo Moro.”
    đź©ş Past Roles:
  • 2021: Researcher at IRCCS-Fondazione Bietti, Rome.
  • 2014-2015: Internships in Ophthalmology and Anesthesiology at Catholic University of Sacred Heart, Rome.

Research Interests

🔍 Dr. Viggiano’s research focuses on:

  • Advanced optical coherence tomography (OCT).
  • Vascular changes in macular diseases.
  • Innovations in cataract and retinal surgery.

Awards

🏆 Nominee for excellence in clinical ophthalmology and scientific research.

Publications Top Notes:

đź“š Highlighted Publications:

Borrelli E, Viggiano P et al., “In Vivo Mapping of the Choriocapillaris in Healthy Eyes.” Ophthalmology Retina, 2019. DOI.

Cited by: Numerous retinal imaging studies.

Borrelli E, Viggiano P, Mastropasqua R., “Vascular Changes in Age-Related Macular Degeneration.” Ann Eye Sci, 2019.

Cited by: Over 20 AMD-focused articles.

Boscia G, Viggiano P et al., “Choroidal Remodeling Following Different Anti-VEGF Therapies in Neovascular AMD.” Scientific Reports, 2024.

Cited by: Studies on anti-VEGF therapies.

Maria Yavropoulou | Health Professions | Best Researcher Award

Posted on by Popular Scientist

Dr. Maria Yavropoulou | Health Professions | Best Researcher Award

Endocrinology Consultant LAIKO University Hospital, Medicine school, national and Kapodistrian University of Athens Greece

Dr. Maria Yavropoulou is a distinguished Endocrinology Consultant at the Endocrinology Unit of the 1st Department of Propaedeutic and Internal Medicine, Medical School of the National and Kapodistrian University of Athens (NKUA). Based at LAIKO University Hospital in Athens, Greece, she specializes in managing endocrine disorders, with a keen focus on rare diseases of calcium and phosphate metabolism.

Profile

Orcid

Education 🎓

  • Medical Degree: Aristotle University of Thessaloniki (AUTh), Greece.
  • Endocrinology Specialization: AHEPA University Hospital, Thessaloniki.
  • Advanced Training: University of Leiden, Netherlands (LUMC), under Prof. Socrates Papapoulos; University of Arkansas, USA (UAMS), under Prof. Stavros Manolagas.
  • Ph.D.: Bone metabolism diseases, Aristotle University of Thessaloniki (AUTh).
  • Master’s Degrees:
    • “Translational Research in Molecular Biology and Genetics” (NKUA).
    • “Epidemiology – Research Methodology in Biomedical Sciences in Clinical Practice and Public Health” (NKUA).

Experience đź©ş

  • Consultant actively managing all endocrine diseases, emphasizing rare calcium and phosphate metabolism disorders.
  • Deputy Head (since 2019): Center for Expertise of Rare Disorders of Calcium and Phosphate Metabolism (C.E.R.E.D), LAIKO Hospital.
  • Patient and Quality Coordinator: Center for Expertise for Adult Langerhans Histiocytosis, Athens.
  • Prestigious Memberships: Member of European Calcified Tissue Society, Steering Committee Member of ESE Educational Programme on Rare Disorders.

Research Interests 🧬

Dr. Yavropoulou’s research focuses on:

  • Bone metabolism and associated molecular mechanisms.
  • Diabetes and its intersection with endocrine disorders.
  • Cortisol production and its impact on rheumatoid arthritis.

Awards 🏆

Dr. Yavropoulou’s exemplary work has earned her numerous accolades, including:

  1. Jens Sandahl Christiansen Award (2020) – European Society of Endocrinology.
  2. G. TOLIS Award (2019) – Hellenic Endocrine Society.
  3. D. IKKOS Awards (2021, 2022) – Clinical Research, Hellenic Endocrine Society.
  4. EJE Rising Star Award (2022) – European Journal of Endocrinology.
  5. Excellence Scholarship in Ph.D. Thesis (2009-2010) – Aristotle University of Thessaloniki.

Publications Top Notes: đź“š

Dr. Yavropoulou has authored numerous impactful publications (134 total, 3164 citations, h-index: 29). Selected works include:

The Association of Vitamin D Receptor Polymorphisms with COVID-19 Severity (2024) – Nutrients.

Diurnal Production of Cortisol and Treatment Response in Rheumatoid Arthritis (2024) – RMD Open.

Transient Osteoporosis Following Denosumab Discontinuation (2024) – Osteoporosis International.

Nocebo-Associated Treatment Discontinuation in Anti-Osteoporotic Drugs (2024) – Maturitas.

Immune System Effects on the Endocrine System (2023) – Endotext.